PBI
66
-2
PFG
45
-7
NSC
62
-2
CNP
62
-6
HD
58
-3
A
41
2
NAVI
55
-2
EXR
62
-2
LRCX
55
9
SLB
53
-3
AFL
49
-3
RSG
68
-6
STX
57
4
SYY
56
-2
LUV
47
2
NOV
59
4
AIG
45
-5
EQR
53
-6
NEE
57
-3
DHR
50
7
PBI
66
-2
PFG
45
-7
NSC
62
-2
CNP
62
-6
HD
58
-3
A
41
2
NAVI
55
-2
EXR
62
-2
LRCX
55
9
SLB
53
-3
AFL
49
-3
RSG
68
-6
STX
57
4
SYY
56
-2
LUV
47
2
NOV
59
4
AIG
45
-5
EQR
53
-6
NEE
57
-3
DHR
50
7
Financhill
Back

Spyre Therapeutics Stock Price Chart

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

SYRE
Spyre Therapeutics

Last Price:
27.51
Seasonality Move:
3.96%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

Spyre Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 27.71 Sell
20-day SMA: 31.58 Sell
50-day SMA: 31.07 Sell
200-day SMA: 31.43 Sell
8-day EMA: 28.28 Sell
20-day EMA: 30.01 Sell
50-day EMA: 30.65 Sell
200-day EMA: 28.81 Sell

Spyre Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.44 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: -300831 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.89 - 36.15) Sell
Bollinger Bands (100): (26.29 - 32.79) Sell

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Spyre Therapeutics Stock

Is Spyre Therapeutics Stock a Buy?

  • Spyre Therapeutics share price is 27.65 while SYRE 8-day simple moving average is 27.71, which is a Sell signal.
  • The stock price of SYRE is 27.65 while Spyre Therapeutics 20-day SMA is 31.58, which makes it a Sell.
  • Spyre Therapeutics 50-day simple moving average is 31.07 while SYRE share price is 27.65, making it a Sell technically.
  • SYRE stock price is 27.65 and Spyre Therapeutics 200-day simple moving average is 31.43, creating a Sell signal.

SYRE Technical Analysis vs Fundamental Analysis

Sell
44
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy or a Sell?

Spyre Therapeutics Stock Info

Market Cap:
1.62B
Price in USD:
27.65
Share Volume:
588.58K

Spyre Therapeutics 52-Week Range

52-Week High:
47.97
52-Week Low:
14.22
Sell
44
Spyre Therapeutics (SYRE) is a Sell

Spyre Therapeutics Share Price Forecast

Is Spyre Therapeutics Stock a Buy?

  • Spyre Therapeutics share price is 27.65 while SYRE 8-day exponential moving average is 28.28, which is a Sell signal.
  • The stock price of SYRE is 27.65 while Spyre Therapeutics 20-day EMA is 30.01, which makes it a Sell.
  • Spyre Therapeutics 50-day exponential moving average is 30.65 while SYRE share price is 27.65, making it a Sell technically.
  • SYRE stock price is 27.65 and Spyre Therapeutics 200-day simple moving average is 28.81, creating a Sell signal.

Fundamental Analysis of Spyre Therapeutics

Is Spyre Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.

Technical Analysis of Spyre Therapeutics

Should I short Spyre Therapeutics stock?

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.